From a fundamentals basis, it's hard for me to rationalize an investment in a company with a three-time loser technology.
Bluntly put, the only thing attractive about GNVC is its market cap provided you ignore the fact that it coincidentally happens to be a biotech company that has proven an inability to get even close to selling a drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.